Skip to the answer
CJC / guidebook

Questioning growth hormone offers

Can a pharmacy make CJC-1295 legally?

Read the rules for pharmacies making CJC-1295 and the meaning of a request that was taken back.

The misconception

The FDA has stopped warning about CJC-1295, so a pharmacy may make it.

What the facts say

As of September 28, 2026, CJC-1295 does not meet the legal rules for use as a pharmacy ingredient. Groups took back their requests to have it allowed. The Food and Drug Administration (FDA) still lists safety concerns; taking a request back is not approval.

See the source notes

Who took back the request, and what was it for?

Compounding means preparing a medicine for a specific order, instead of providing a drug company’s finished product.

Groups asked the FDA, the Food and Drug Administration, to allow CJC-1295 as a compounding ingredient.

Those groups took their requests back. That is what “withdrawn” means; the FDA did not grant the requests.

The FDA page marked April 22, 2026 still lists safety concerns beside CJC-1295.

That is the date of the page. The FDA does not say when each group took its request back.

Why an ordinary pharmacy cannot use this ingredient

As of September 28, 2026, an ordinary pharmacy cannot legally use CJC-1295 to make a medicine to order. It meets none of the ingredient rules below.

  • No official written standard sets out the quality checks for CJC-1295 under this part of the law. This is a missing document, not a failed test on a batch.
  • It is not an ingredient in an FDA-approved drug.
  • It is absent from the allowed-ingredient list.

Larger facilities that make medicines to order follow separate federal rules. Those rules also do not permit CJC-1295 as an ingredient, based on records checked September 28, 2026.

This is about this ingredient

As of September 26, 2026, compounding itself can be lawful when the relevant rules are met.

Each ingredient must still meet the legal rules for use in a medicine made to order.

A doctor or other health professional with permission to prescribe gives a medicine order called a prescription.

Even with a prescription, CJC-1295 does not meet the ingredient rules described above.

What a vote can tell you

An advisory panel is a group that gives advice to the FDA. At its December 4, 2024 meeting, it advised against allowing any CJC-1295 form it considered on the ingredient list.

An advisory panel gives advice; its vote does not make a final rule.

No final CJC-1295 rule appeared in the records checked as of September 28, 2026.

Even without a final FDA rule, CJC-1295 still does not meet the ingredient rules listed above.

Ask for the basis, in writing

Which rule allows this exact ingredient, and where can I read it?

Open the evidence

The pharmacy ingredient rules and FDA decisions were checked September 28, 2026.

The first link shows the requests taken back and the safety concerns that remain. The next links explain the ingredient rules and record the group’s advice to the FDA.

Keep readingWhat a proper care visit can answer